DE2509562A1 - Thienobenzopyran- und thiopyranobenzopyranester, verfahren zu deren herstellung und diese enthaltende arzneimittel - Google Patents

Thienobenzopyran- und thiopyranobenzopyranester, verfahren zu deren herstellung und diese enthaltende arzneimittel

Info

Publication number
DE2509562A1
DE2509562A1 DE19752509562 DE2509562A DE2509562A1 DE 2509562 A1 DE2509562 A1 DE 2509562A1 DE 19752509562 DE19752509562 DE 19752509562 DE 2509562 A DE2509562 A DE 2509562A DE 2509562 A1 DE2509562 A1 DE 2509562A1
Authority
DE
Germany
Prior art keywords
methyl
dihydro
benzopyran
carbon atoms
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19752509562
Other languages
German (de)
English (en)
Inventor
Louis Selig Harris
Harry George Pars
Ray Kumar Razdan
John Clark Sheehan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sharps Associates
Original Assignee
Sharps Associates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/448,401 external-priority patent/US3960871A/en
Application filed by Sharps Associates filed Critical Sharps Associates
Publication of DE2509562A1 publication Critical patent/DE2509562A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752509562 1974-03-05 1975-03-05 Thienobenzopyran- und thiopyranobenzopyranester, verfahren zu deren herstellung und diese enthaltende arzneimittel Ceased DE2509562A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/448,401 US3960871A (en) 1971-12-27 1974-03-05 Esters of thienobenzopyrans and thiopyranobenzopyrans

Publications (1)

Publication Number Publication Date
DE2509562A1 true DE2509562A1 (de) 1975-09-11

Family

ID=23780170

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752509562 Ceased DE2509562A1 (de) 1974-03-05 1975-03-05 Thienobenzopyran- und thiopyranobenzopyranester, verfahren zu deren herstellung und diese enthaltende arzneimittel

Country Status (4)

Country Link
DE (1) DE2509562A1 (enExample)
FR (1) FR2262980B2 (enExample)
GB (1) GB1489486A (enExample)
SE (1) SE422687B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6016989A (ja) * 1983-07-06 1985-01-28 Shionogi & Co Ltd オキソ飽和異項環カルボンアミドセフエム化合物

Also Published As

Publication number Publication date
GB1489486A (en) 1977-10-19
SE422687B (sv) 1982-03-22
SE7502409L (enExample) 1975-09-08
FR2262980B2 (enExample) 1982-07-16
FR2262980A2 (enExample) 1975-10-03

Similar Documents

Publication Publication Date Title
DE3852266T2 (de) Azaspirane mit immunmodulierender Wirkung.
DE2451932C2 (de) dl-trans-1-Hydroxy-und dl-trans-1-Alkanoyloxy-3-alkyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-one, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Zubereitungen
CH648553A5 (de) Neue 3,4-dihydro-5h-2,3-benzodiazepin-derivate und verfahren zur herstellung derselben.
DE2923368C2 (enExample)
EP0079556A2 (de) Morphinanderivate, ihre Herstellung, sowie diese enthaltende Arzeimittel
DE2710242A1 (de) 5-eckige klammer auf 1,1-diphenyl- 3-(5- oder 6-hydroxy-2-azabicyclo eckige klammer auf 2,2,2 eckige klammer zu oct-2-yl)propyl eckige klammer zu -2- alkyl-1,3,4-oxadiazole und verwandte verbindungen
DE3623300A1 (de) 7-acyloxy-6-aminoacyloxypolyoxylabdane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2418344A1 (de) Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung
US4025630A (en) Anesthesia methods using benzopyrans and esters thereof as pre-anesthesia medication
DE3038966C2 (enExample)
DE2263100A1 (de) Neue heterozyklische ester von benzopyranopyridinen
DE60012750T2 (de) Neue xanthon derivate, deren herstellung und verwendung als arzneimittel
DE2945701A1 (de) S-triazinone und s-triazinthione, verfahren zu deren herstellung und diese verbindungen enthaltende therapeutische zubereitungen
CH634839A5 (de) Pyranochromonderivate und ihre verwendung in arzneimitteln zur behandlung von allergien.
EP0313935B1 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2416491A1 (de) Heterocyclische ester von alkylphenylbenzopyranen
CH644121A5 (de) 9h-pyrido(3,4-b)indol-derivate.
DE3535928A1 (de) Tetrahydro-(beta)-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE68905361T2 (de) Trienische Derivate mit chromenischer Struktur, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
DE2441206A1 (de) 1- oder 2-mono- und -dialkylsubstituierte thienobenzopyrane
EP0172526B1 (de) Neue Benzodiazepine, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2521920A1 (de) Neue derivate von 1h-triazolo(4,5-c) pyridin-7-carbonsaeuren und -saeureestern
DE2917890C2 (enExample)
DE2627190A1 (de) Neue fuenfring-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2550163A1 (de) Neue derivate des eckige klammer auf 1,4 eckige klammer zu oxathiino eckige klammer auf 2,3-c eckige klammer zu pyrrols, deren herstellung und diese enthaltende zusammensetzungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8131 Rejection